mProX™ Human OXGR1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- GPCR Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Edwiin
Verified Customer
Ophelia
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 OXGR1 overexpression in cardiomyocytes inhibited phenylephrine-induced hypertrophy.
Adenovirus infection with human OXGR1 (Ad-OXGR1) results in the expression of OXGR1 in neonatal rat cardiomyocytes (NRCM), as shown by a Western blot study. Ad-LacZ, an adenovirus that expresses LacZ, was utilized as a control.
Ref: Omede, Ameh, et al. "The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice." Biochemical and biophysical research communications 479.4 (2016): 708-714.
Pubmed: 27693579
DOI: 10.1016/j.bbrc.2016.09.147
Research Highlights
Immune-responsive gene 1 (IRG1) is rapidly induced in myeloid lineage cells by pathogens and inflammatory conditions. The immunomodulatory metabolite itaconate (ITA) is produced by the aconitate decarboxylase (ACOD1) encoded by the IRG1 gene.
Zeng, Yi-Rong, et al. "The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response." The Journal of Clinical Investigation 133.6 (2023).
Pubmed:
36919698
DOI:
10.1172/JCI160463
These results demonstrate a hitherto unrecognized mechanism for the beneficial effects of resistance training, utilizing systemically generated AKG as an adrenal stimulator of muscle hypertrophy and fat loss.
Yuan, Yexian, et al. "Exercise-induced α-ketoglutaric acid stimulates muscle hypertrophy and fat loss through OXGR1-dependent adrenal activation." The EMBO Journal 39.7 (2020): e103304.
Pubmed:
32104923
DOI:
10.15252/embj.2019103304